

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.35690704 |
| 2 | negative regulation of mast cell activation (GO:0033004) | 5.42975371 |
| 3 | DNA deamination (GO:0045006) | 5.04972560 |
| 4 | innate immune response in mucosa (GO:0002227) | 4.71689427 |
| 5 | growth hormone receptor signaling pathway (GO:0060396) | 4.68817296 |
| 6 | negative regulation of leukocyte chemotaxis (GO:0002689) | 4.63618452 |
| 7 | xenobiotic catabolic process (GO:0042178) | 4.57790078 |
| 8 | erythrocyte maturation (GO:0043249) | 4.41660035 |
| 9 | protein neddylation (GO:0045116) | 4.27458174 |
| 10 | cellular response to growth hormone stimulus (GO:0071378) | 4.25204368 |
| 11 | response to misfolded protein (GO:0051788) | 4.18027634 |
| 12 | beta-amyloid metabolic process (GO:0050435) | 4.15919921 |
| 13 | negative regulation of B cell apoptotic process (GO:0002903) | 4.14517551 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.00585291 |
| 15 | regulation of memory T cell differentiation (GO:0043380) | 4.00076418 |
| 16 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.95981506 |
| 17 | mucosal immune response (GO:0002385) | 3.90261709 |
| 18 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.88282748 |
| 19 | regulation of macrophage chemotaxis (GO:0010758) | 3.85788474 |
| 20 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.80184952 |
| 21 | granulocyte differentiation (GO:0030851) | 3.79305777 |
| 22 | response to nitrosative stress (GO:0051409) | 3.69115294 |
| 23 | mast cell activation involved in immune response (GO:0002279) | 3.60696292 |
| 24 | mast cell degranulation (GO:0043303) | 3.60696292 |
| 25 | multicellular organism reproduction (GO:0032504) | 3.60397847 |
| 26 | organ or tissue specific immune response (GO:0002251) | 3.57300963 |
| 27 | positive regulation of protein homodimerization activity (GO:0090073) | 3.55469706 |
| 28 | adenosine metabolic process (GO:0046085) | 3.53087228 |
| 29 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 3.50899547 |
| 30 | B cell mediated immunity (GO:0019724) | 3.49827164 |
| 31 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.49266760 |
| 32 | antibacterial humoral response (GO:0019731) | 3.48249600 |
| 33 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.42214655 |
| 34 | determination of adult lifespan (GO:0008340) | 3.39911327 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38395804 |
| 36 | cullin deneddylation (GO:0010388) | 3.38012837 |
| 37 | platelet dense granule organization (GO:0060155) | 3.31943910 |
| 38 | fucose catabolic process (GO:0019317) | 3.29706953 |
| 39 | L-fucose metabolic process (GO:0042354) | 3.29706953 |
| 40 | L-fucose catabolic process (GO:0042355) | 3.29706953 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.29540236 |
| 42 | negative regulation of protein oligomerization (GO:0032460) | 3.28722872 |
| 43 | histone H2A acetylation (GO:0043968) | 3.28323000 |
| 44 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.26827747 |
| 45 | meiotic chromosome segregation (GO:0045132) | 3.22431006 |
| 46 | replication fork processing (GO:0031297) | 3.22352421 |
| 47 | regulation of B cell apoptotic process (GO:0002902) | 3.14788170 |
| 48 | mannosylation (GO:0097502) | 3.12927198 |
| 49 | negative regulation of histone acetylation (GO:0035067) | 3.05421743 |
| 50 | neuronal action potential propagation (GO:0019227) | 3.05172914 |
| 51 | antimicrobial humoral response (GO:0019730) | 3.04874124 |
| 52 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.99520952 |
| 53 | branched-chain amino acid catabolic process (GO:0009083) | 2.98774916 |
| 54 | peptide catabolic process (GO:0043171) | 2.98682928 |
| 55 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.95146318 |
| 56 | negative regulation of viral entry into host cell (GO:0046597) | 2.93743834 |
| 57 | response to growth hormone (GO:0060416) | 2.93329491 |
| 58 | regulation of autophagic vacuole assembly (GO:2000785) | 2.92419227 |
| 59 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84937339 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84937339 |
| 61 | protein deneddylation (GO:0000338) | 2.83448615 |
| 62 | dopamine transport (GO:0015872) | 2.83440946 |
| 63 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83317079 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.82728936 |
| 65 | regulation of heat generation (GO:0031650) | 2.82271373 |
| 66 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.81042717 |
| 67 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.80769311 |
| 68 | regulation of thymocyte apoptotic process (GO:0070243) | 2.79139412 |
| 69 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.77740524 |
| 70 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.77740524 |
| 71 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.77740524 |
| 72 | nucleosome assembly (GO:0006334) | 2.77362143 |
| 73 | response to interferon-beta (GO:0035456) | 2.76895137 |
| 74 | plasma membrane fusion (GO:0045026) | 2.75003753 |
| 75 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72381970 |
| 76 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72381970 |
| 77 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.70878129 |
| 78 | hormone catabolic process (GO:0042447) | 2.70600886 |
| 79 | ubiquinone biosynthetic process (GO:0006744) | 2.70127603 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 2.69537514 |
| 81 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.69351162 |
| 82 | sulfation (GO:0051923) | 2.68445267 |
| 83 | male meiosis (GO:0007140) | 2.68321178 |
| 84 | mast cell activation (GO:0045576) | 2.68297753 |
| 85 | positive regulation of ligase activity (GO:0051351) | 2.68234798 |
| 86 | cytidine deamination (GO:0009972) | 2.67810590 |
| 87 | cytidine metabolic process (GO:0046087) | 2.67810590 |
| 88 | cytidine catabolic process (GO:0006216) | 2.67810590 |
| 89 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.65881915 |
| 90 | autophagic vacuole fusion (GO:0000046) | 2.65849414 |
| 91 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.63855599 |
| 92 | regulation of vacuole organization (GO:0044088) | 2.63831319 |
| 93 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.63458145 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.62399505 |
| 95 | histone H2B ubiquitination (GO:0033523) | 2.62041010 |
| 96 | regulation of protein homooligomerization (GO:0032462) | 2.61824161 |
| 97 | urate metabolic process (GO:0046415) | 2.61355701 |
| 98 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.59761972 |
| 99 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.59512908 |
| 100 | positive regulation of response to oxidative stress (GO:1902884) | 2.59117117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.57323258 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.76157654 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.39323401 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09118140 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03691761 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87511980 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.87169878 |
| 8 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.82676294 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82501529 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.75405674 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.67157921 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.62729118 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.45805632 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.21915212 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07875119 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.06494161 |
| 17 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.00864825 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00806832 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99335033 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96193617 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.95293202 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.89972995 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84429615 |
| 24 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.78365212 |
| 25 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.78216568 |
| 26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.76019532 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75526826 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75377726 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.69969062 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69885978 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68712934 |
| 32 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.65870868 |
| 33 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.65162357 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.63532738 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.61648548 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59771479 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59614567 |
| 38 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.58060326 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57801353 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54319586 |
| 41 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50829629 |
| 42 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49971616 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.47133573 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43878921 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43640353 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43549404 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43366967 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34461274 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31749754 |
| 50 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30584819 |
| 51 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30584819 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29110973 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28304123 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27914190 |
| 55 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26355981 |
| 56 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.26268936 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25541244 |
| 58 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24424095 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23898169 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.23623482 |
| 61 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.20467286 |
| 62 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.19845396 |
| 63 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.17930272 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.17670848 |
| 65 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.15868095 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13151561 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13150294 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12508887 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11954327 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11768771 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11268641 |
| 72 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10849308 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10677123 |
| 74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10488708 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09080864 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05768316 |
| 77 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04736371 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04334060 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03439986 |
| 80 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02979555 |
| 81 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.02408545 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01749299 |
| 83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01634480 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01315061 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.01236527 |
| 86 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01087337 |
| 87 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00261359 |
| 88 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99275749 |
| 89 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98599186 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98333414 |
| 91 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97544378 |
| 92 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96175118 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96062544 |
| 94 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.95913452 |
| 95 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95628218 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.95566927 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93555148 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92867148 |
| 99 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.92788083 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92544040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 6.29405477 |
| 2 | MP0005464_abnormal_platelet_physiology | 3.90103147 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.14484842 |
| 4 | MP0006054_spinal_hemorrhage | 2.97128670 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.91012856 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.68256242 |
| 7 | MP0008872_abnormal_physiological_respon | 2.58236933 |
| 8 | MP0000613_abnormal_salivary_gland | 2.52859337 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.52692447 |
| 10 | MP0008995_early_reproductive_senescence | 2.50350119 |
| 11 | MP0000647_abnormal_sebaceous_gland | 2.49734771 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.40585256 |
| 13 | MP0000383_abnormal_hair_follicle | 2.30260088 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.28011107 |
| 15 | MP0008004_abnormal_stomach_pH | 2.22323817 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.06310675 |
| 17 | MP0000685_abnormal_immune_system | 1.98762267 |
| 18 | MP0005671_abnormal_response_to | 1.89041497 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 1.83891855 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.80413529 |
| 21 | MP0003724_increased_susceptibility_to | 1.73154541 |
| 22 | MP0000427_abnormal_hair_cycle | 1.66484424 |
| 23 | MP0002006_tumorigenesis | 1.65544179 |
| 24 | MP0003011_delayed_dark_adaptation | 1.62184076 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.59730091 |
| 26 | MP0003646_muscle_fatigue | 1.58545129 |
| 27 | MP0001853_heart_inflammation | 1.54480578 |
| 28 | MP0001873_stomach_inflammation | 1.53418873 |
| 29 | MP0004742_abnormal_vestibular_system | 1.52723443 |
| 30 | MP0009053_abnormal_anal_canal | 1.51398819 |
| 31 | MP0001727_abnormal_embryo_implantation | 1.50943435 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.47252848 |
| 33 | MP0002282_abnormal_trachea_morphology | 1.42410751 |
| 34 | MP0009697_abnormal_copulation | 1.42179898 |
| 35 | MP0010678_abnormal_skin_adnexa | 1.39562723 |
| 36 | MP0005410_abnormal_fertilization | 1.38090795 |
| 37 | MP0003786_premature_aging | 1.36942445 |
| 38 | MP0005360_urolithiasis | 1.35092953 |
| 39 | MP0008932_abnormal_embryonic_tissue | 1.33418793 |
| 40 | MP0004947_skin_inflammation | 1.25816137 |
| 41 | MP0004043_abnormal_pH_regulation | 1.23678343 |
| 42 | MP0008058_abnormal_DNA_repair | 1.22425147 |
| 43 | MP0001800_abnormal_humoral_immune | 1.21715012 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.19844741 |
| 45 | MP0005310_abnormal_salivary_gland | 1.18592550 |
| 46 | MP0004381_abnormal_hair_follicle | 1.17059447 |
| 47 | MP0002398_abnormal_bone_marrow | 1.15645778 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.13842367 |
| 49 | MP0003879_abnormal_hair_cell | 1.13611793 |
| 50 | MP0004147_increased_porphyrin_level | 1.12697802 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.11867407 |
| 52 | MP0002102_abnormal_ear_morphology | 1.11136727 |
| 53 | MP0003718_maternal_effect | 1.05871951 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.02437196 |
| 55 | MP0005387_immune_system_phenotype | 1.01468688 |
| 56 | MP0001790_abnormal_immune_system | 1.01468688 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.99025630 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 0.97984945 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 0.95244091 |
| 60 | MP0002722_abnormal_immune_system | 0.94367300 |
| 61 | MP0002452_abnormal_antigen_presenting | 0.93243729 |
| 62 | MP0002723_abnormal_immune_serum | 0.93050199 |
| 63 | MP0005535_abnormal_body_temperature | 0.92192530 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 0.92175965 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.92128987 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.92128987 |
| 67 | MP0009764_decreased_sensitivity_to | 0.91156904 |
| 68 | MP0009785_altered_susceptibility_to | 0.90502461 |
| 69 | MP0004084_abnormal_cardiac_muscle | 0.87897733 |
| 70 | MP0005332_abnormal_amino_acid | 0.87050858 |
| 71 | MP0003186_abnormal_redox_activity | 0.85292891 |
| 72 | MP0002210_abnormal_sex_determination | 0.85292533 |
| 73 | MP0000343_altered_response_to | 0.84887937 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.84609204 |
| 75 | MP0005379_endocrine/exocrine_gland_phen | 0.84000214 |
| 76 | MP0002429_abnormal_blood_cell | 0.82291704 |
| 77 | MP0004510_myositis | 0.82154990 |
| 78 | MP0002420_abnormal_adaptive_immunity | 0.81718065 |
| 79 | MP0001764_abnormal_homeostasis | 0.81377910 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.80500768 |
| 81 | MP0005389_reproductive_system_phenotype | 0.79645303 |
| 82 | MP0001819_abnormal_immune_cell | 0.78621405 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.78219645 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.76887439 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 0.76206897 |
| 86 | MP0001929_abnormal_gametogenesis | 0.74393701 |
| 87 | MP0001501_abnormal_sleep_pattern | 0.73059780 |
| 88 | MP0002736_abnormal_nociception_after | 0.73029987 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.72849718 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.72810764 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.72186733 |
| 92 | MP0000653_abnormal_sex_gland | 0.72033682 |
| 93 | MP0001919_abnormal_reproductive_system | 0.71156978 |
| 94 | MP0002272_abnormal_nervous_system | 0.71008137 |
| 95 | MP0004142_abnormal_muscle_tone | 0.70979522 |
| 96 | MP0008057_abnormal_DNA_replication | 0.70468501 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.70131852 |
| 98 | MP0009046_muscle_twitch | 0.69793818 |
| 99 | MP0001851_eye_inflammation | 0.69024650 |
| 100 | MP0000716_abnormal_immune_system | 0.68252910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 3-Methylglutaconic aciduria (HP:0003535) | 4.73261244 |
| 2 | Petechiae (HP:0000967) | 4.69880531 |
| 3 | Prolonged bleeding time (HP:0003010) | 4.56537699 |
| 4 | Autoamputation (HP:0001218) | 4.37860845 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.06750157 |
| 6 | Prostate neoplasm (HP:0100787) | 3.85575303 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.56000836 |
| 8 | Menorrhagia (HP:0000132) | 3.18258650 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.17784961 |
| 10 | Hypomagnesemia (HP:0002917) | 3.14128873 |
| 11 | Acute encephalopathy (HP:0006846) | 3.07294427 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.02552391 |
| 13 | Abnormality of the prostate (HP:0008775) | 3.00714319 |
| 14 | Increased mean platelet volume (HP:0011877) | 2.98887300 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 2.96597399 |
| 16 | Epistaxis (HP:0000421) | 2.93305636 |
| 17 | Purpura (HP:0000979) | 2.85694069 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 2.83828922 |
| 19 | Abnormality of the parathyroid morphology (HP:0011766) | 2.80837289 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 2.78833666 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 2.74289756 |
| 22 | Chronic sinusitis (HP:0011109) | 2.72941050 |
| 23 | Abnormal platelet volume (HP:0011876) | 2.72686911 |
| 24 | Poor speech (HP:0002465) | 2.68800042 |
| 25 | Cerebral edema (HP:0002181) | 2.66570688 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 2.62994393 |
| 27 | Hypoplasia of the fovea (HP:0007750) | 2.61866810 |
| 28 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.61866810 |
| 29 | Mitochondrial inheritance (HP:0001427) | 2.57376689 |
| 30 | Dry hair (HP:0011359) | 2.53598766 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 2.53394939 |
| 32 | Hyperalaninemia (HP:0003348) | 2.53394939 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.53394939 |
| 34 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.49023278 |
| 35 | Exertional dyspnea (HP:0002875) | 2.46241551 |
| 36 | Congenital, generalized hypertrichosis (HP:0004540) | 2.45510565 |
| 37 | Abnormality of magnesium homeostasis (HP:0004921) | 2.44107067 |
| 38 | Increased CSF lactate (HP:0002490) | 2.41205610 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34821911 |
| 40 | Increased serum lactate (HP:0002151) | 2.33445991 |
| 41 | Pancreatic fibrosis (HP:0100732) | 2.33361633 |
| 42 | Large eyes (HP:0001090) | 2.30274467 |
| 43 | Abnormal glycosylation (HP:0012345) | 2.30065245 |
| 44 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.30065245 |
| 45 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.30065245 |
| 46 | Abnormal protein glycosylation (HP:0012346) | 2.30065245 |
| 47 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.29471999 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.29187310 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.29187310 |
| 50 | Clubbing of toes (HP:0100760) | 2.26896820 |
| 51 | Chronic otitis media (HP:0000389) | 2.18927378 |
| 52 | Polyuria (HP:0000103) | 2.15289844 |
| 53 | Attenuation of retinal blood vessels (HP:0007843) | 2.13971808 |
| 54 | Poikilocytosis (HP:0004447) | 2.12018149 |
| 55 | True hermaphroditism (HP:0010459) | 2.11922184 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.09043979 |
| 57 | Abnormality of the fovea (HP:0000493) | 2.06915041 |
| 58 | Cerebellar dysplasia (HP:0007033) | 2.05070630 |
| 59 | Hypokalemic alkalosis (HP:0001949) | 1.99442934 |
| 60 | Osteomyelitis (HP:0002754) | 1.99248822 |
| 61 | Type II lissencephaly (HP:0007260) | 1.99144881 |
| 62 | Fair hair (HP:0002286) | 1.96764577 |
| 63 | Recurrent sinusitis (HP:0011108) | 1.96177491 |
| 64 | Hyperlipoproteinemia (HP:0010980) | 1.94070982 |
| 65 | Lethargy (HP:0001254) | 1.93822591 |
| 66 | Impaired platelet aggregation (HP:0003540) | 1.92472084 |
| 67 | Abnormal platelet function (HP:0011869) | 1.92472084 |
| 68 | Retinal dysplasia (HP:0007973) | 1.92304385 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 1.91982041 |
| 70 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91982041 |
| 71 | Pancreatic cysts (HP:0001737) | 1.88550277 |
| 72 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87833572 |
| 73 | Lactic acidosis (HP:0003128) | 1.87773248 |
| 74 | Increased muscle lipid content (HP:0009058) | 1.87311787 |
| 75 | Generalized aminoaciduria (HP:0002909) | 1.87017485 |
| 76 | Metabolic alkalosis (HP:0200114) | 1.85184372 |
| 77 | Amblyopia (HP:0000646) | 1.84040101 |
| 78 | Abnormality of the fingertips (HP:0001211) | 1.83544630 |
| 79 | Alkalosis (HP:0001948) | 1.81505961 |
| 80 | Hyperventilation (HP:0002883) | 1.79658902 |
| 81 | Gingival bleeding (HP:0000225) | 1.79531006 |
| 82 | Congenital stationary night blindness (HP:0007642) | 1.78477583 |
| 83 | Pachygyria (HP:0001302) | 1.76090575 |
| 84 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.75394668 |
| 85 | Poor head control (HP:0002421) | 1.74785454 |
| 86 | Abnormality of lateral ventricle (HP:0030047) | 1.74272634 |
| 87 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.74068832 |
| 88 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.73545986 |
| 89 | Methylmalonic acidemia (HP:0002912) | 1.72583209 |
| 90 | Abnormal urine output (HP:0012590) | 1.71694998 |
| 91 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.70587077 |
| 92 | Opisthotonus (HP:0002179) | 1.70267235 |
| 93 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.70175185 |
| 94 | Ridged nail (HP:0001807) | 1.69214047 |
| 95 | Erythema (HP:0010783) | 1.68788587 |
| 96 | Abnormality of B cell number (HP:0010975) | 1.67514609 |
| 97 | Squamous cell carcinoma (HP:0002860) | 1.65190203 |
| 98 | Optic disc pallor (HP:0000543) | 1.65166842 |
| 99 | Azoospermia (HP:0000027) | 1.64322810 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.64068595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRSK2 | 6.97100220 |
| 2 | ZAK | 4.31810733 |
| 3 | WEE1 | 3.97137094 |
| 4 | TLK1 | 3.88980298 |
| 5 | MST4 | 3.44935943 |
| 6 | VRK2 | 2.86690031 |
| 7 | BRSK1 | 2.84696198 |
| 8 | NUAK1 | 2.71191379 |
| 9 | VRK1 | 2.57089243 |
| 10 | EIF2AK1 | 2.38786636 |
| 11 | FRK | 2.19724979 |
| 12 | FER | 1.89089284 |
| 13 | KIT | 1.88608627 |
| 14 | BMPR1B | 1.82430223 |
| 15 | TAF1 | 1.73711993 |
| 16 | PDK2 | 1.72736827 |
| 17 | MKNK2 | 1.66226131 |
| 18 | ADRBK2 | 1.64812752 |
| 19 | PBK | 1.53336850 |
| 20 | ACVR1B | 1.53146443 |
| 21 | PINK1 | 1.45239745 |
| 22 | PNCK | 1.44917523 |
| 23 | GRK5 | 1.30098453 |
| 24 | MAPKAPK3 | 1.29106093 |
| 25 | RIPK4 | 1.26811735 |
| 26 | SMG1 | 1.25211637 |
| 27 | PKN1 | 1.15470047 |
| 28 | SYK | 1.11735251 |
| 29 | CAMK1G | 1.09580498 |
| 30 | CDK8 | 1.04212632 |
| 31 | PIK3CG | 1.00197846 |
| 32 | PLK2 | 0.99856453 |
| 33 | DAPK3 | 0.98999459 |
| 34 | RPS6KA5 | 0.88498607 |
| 35 | MAPKAPK5 | 0.87996175 |
| 36 | WNK4 | 0.85872671 |
| 37 | STK4 | 0.83773139 |
| 38 | CDK4 | 0.82867507 |
| 39 | PLK4 | 0.82580014 |
| 40 | IKBKB | 0.81524423 |
| 41 | MYLK | 0.79864199 |
| 42 | AURKA | 0.78505015 |
| 43 | PLK3 | 0.77333202 |
| 44 | MARK3 | 0.76476201 |
| 45 | MKNK1 | 0.75175841 |
| 46 | EIF2AK2 | 0.72616700 |
| 47 | WNK3 | 0.72393285 |
| 48 | MAPK13 | 0.69776021 |
| 49 | CHEK2 | 0.68895978 |
| 50 | GRK1 | 0.67978520 |
| 51 | ATR | 0.66611249 |
| 52 | CAMKK2 | 0.65293526 |
| 53 | ERBB3 | 0.64209845 |
| 54 | ADRBK1 | 0.63007566 |
| 55 | BCKDK | 0.59697653 |
| 56 | MAP4K1 | 0.57633750 |
| 57 | CSF1R | 0.57326197 |
| 58 | GRK7 | 0.55081213 |
| 59 | LYN | 0.53784480 |
| 60 | PTK2B | 0.52888335 |
| 61 | IRAK1 | 0.51711720 |
| 62 | KDR | 0.50808341 |
| 63 | CAMK1 | 0.50106328 |
| 64 | PLK1 | 0.49676058 |
| 65 | TEC | 0.49208718 |
| 66 | CDC7 | 0.49124873 |
| 67 | PRKAA1 | 0.48754967 |
| 68 | CSNK1G3 | 0.47389917 |
| 69 | IKBKE | 0.45741307 |
| 70 | CSNK1G1 | 0.42410502 |
| 71 | CDK9 | 0.42126235 |
| 72 | MAP4K2 | 0.40793650 |
| 73 | FLT3 | 0.39738542 |
| 74 | BTK | 0.38220197 |
| 75 | PIM1 | 0.38037616 |
| 76 | STK3 | 0.37739877 |
| 77 | STK24 | 0.37719583 |
| 78 | TYRO3 | 0.37633676 |
| 79 | CDK3 | 0.36298812 |
| 80 | DAPK1 | 0.34585722 |
| 81 | BMPR2 | 0.33932060 |
| 82 | JAK3 | 0.32681570 |
| 83 | TRIM28 | 0.30428378 |
| 84 | DYRK2 | 0.29801406 |
| 85 | NME1 | 0.29659070 |
| 86 | HIPK2 | 0.29083691 |
| 87 | IRAK2 | 0.28123273 |
| 88 | PRKCA | 0.26830420 |
| 89 | ILK | 0.25740778 |
| 90 | SIK3 | 0.25137723 |
| 91 | BMX | 0.24414097 |
| 92 | EPHA3 | 0.23656816 |
| 93 | PHKG2 | 0.23315453 |
| 94 | PHKG1 | 0.23315453 |
| 95 | EPHB2 | 0.22898474 |
| 96 | PRKG1 | 0.22832416 |
| 97 | AURKB | 0.22475500 |
| 98 | CSNK1G2 | 0.22399517 |
| 99 | TAOK3 | 0.22367205 |
| 100 | MAP3K10 | 0.22082140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 6.00112628 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.51695347 |
| 3 | Alcoholism_Homo sapiens_hsa05034 | 3.49189528 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.24831876 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.22856022 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.04562050 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.99967322 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.98549987 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.98117564 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34536974 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.31381081 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25607775 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91655286 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84384988 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73155694 |
| 16 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.71294034 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69953883 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.60459551 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.60285107 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49735365 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45231017 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37312900 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.33730555 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33365694 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28406868 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17772111 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17668384 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17621983 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.14915865 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13968982 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13550791 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11872181 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11779505 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.10400395 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07424294 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04629433 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04098171 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97192913 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95971427 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95724551 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 0.90528557 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88773894 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 0.85940040 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84214917 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81065013 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 0.80444239 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78974091 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78458319 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76486951 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76224706 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.75848227 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75698820 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75457020 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.74110931 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.72330832 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68847154 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68707025 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68546916 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.68273212 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65876083 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 0.63574905 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63535289 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63412283 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63043599 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63011969 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61605690 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61015388 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58202933 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54983266 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50964846 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50537294 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49410175 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48793442 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.47549675 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45063142 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44726638 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44296702 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.42821408 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.40995202 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38491531 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38327315 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38175712 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.38001971 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.37173053 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36305277 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31994338 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31305531 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31152202 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30873278 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29076919 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28749398 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27857909 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27832367 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25971724 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25579184 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.24642229 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22980399 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18667737 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.17340496 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.17122555 |

